Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.
Curr Pharm Biotechnol
; 20(6): 483-488, 2019.
Article
in En
| MEDLINE
| ID: mdl-30961491
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carrier Proteins
/
Biomarkers, Tumor
/
Endometrial Neoplasms
/
Neovascularization, Pathologic
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Curr Pharm Biotechnol
Year:
2019
Document type:
Article